Sabre Insurance Group plc (SBREF)

Theseus Pharmaceuticals Income Statement

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Premiums & Annuity Revenue	210.53	214.51	159.74	156.52	145.44	165.71
Total Interest & Dividend Income	4.76	3.25	-2.81	-1.18	1.21	1.42
Gain (Loss) on Sale of Investments	-0.01	-	-	0.02	-0.02	-
Other Revenue	-	-	-	-	6.02	6.78
Total Revenue	215.28	217.76	156.93	155.36	152.66	173.9
Revenue Growth (YoY)	13.44%	38.76%	1.01%	1.77%	-12.22%	-8.94%
Policy Benefits	143.94	129.75	92.13	120.65	81.02	88.11
Policy Acquisition & Underwriting Costs	17.86	18.17	14.06	12.94	12.94	14.29
Selling, General & Administrative	1.76	1.61	1.61	1.6	21.49	22.31
Other Operating Expenses	-1.44	20.42	26.76	7.93	-	-
Total Operating Expenses	162.12	169.94	134.55	143.12	115.44	124.7
Operating Income	53.17	47.82	22.38	12.24	37.22	49.2
Interest Expense	-	-	-	-0.01	-0.02	-0.01
Other Non Operating Income (Expenses)	0.65	0.74	1.23	1.78	-	-
EBT Excluding Unusual Items	53.82	48.56	23.61	14.02	37.2	49.19
Asset Writedown	-	-	-	-	-	-0.07
Pretax Income	53.82	48.56	23.61	14.02	37.2	49.12
Income Tax Expense	14.04	12.6	5.55	2.94	7.06	9.32
Net Income	39.77	35.96	18.07	11.08	30.14	39.8
Net Income to Common	39.77	35.96	18.07	11.08	30.14	39.8
Net Income Growth	35.52%	99.06%	63.07%	-63.24%	-24.27%	-12.94%
Shares Outstanding (Basic)	248	248	249	249	249	249
Shares Outstanding (Diluted)	251	250	251	251	252	252
Shares Change (YoY)	0.15%	-0.21%	0.04%	-0.32%	-0.01%	0.25%
EPS (Basic)	0.16	0.14	0.07	0.04	0.12	0.16
EPS (Diluted)	0.16	0.14	0.07	0.04	0.12	0.16
EPS Growth	35.36%	99.58%	62.90%	-63.10%	-24.27%	-13.17%
Free Cash Flow	32.28	22.07	23.68	19.36	33.29	50.68
Free Cash Flow Per Share	0.13	0.09	0.09	0.08	0.13	0.20
Dividend Per Share	0.118	0.101	0.051	0.045	0.084	0.111
Dividend Growth	100.00%	98.04%	13.33%	-46.43%	-24.32%	-13.28%
Operating Margin	24.70%	21.96%	14.26%	7.88%	24.38%	28.29%
Profit Margin	18.48%	16.51%	11.51%	7.13%	19.74%	22.88%
Free Cash Flow Margin	15.00%	10.13%	15.09%	12.46%	21.80%	29.14%
EBITDA	53.32	48.01	22.52	12.35	37.35	49.38
EBITDA Margin	24.77%	22.05%	14.35%	7.95%	24.47%	28.39%
D&A For EBITDA	0.15	0.18	0.14	0.11	0.14	0.18
EBIT	53.17	47.82	22.38	12.24	37.22	49.2
EBIT Margin	24.70%	21.96%	14.26%	7.88%	24.38%	28.29%
Effective Tax Rate	26.09%	25.95%	23.50%	20.98%	18.98%	18.98%
Revenue as Reported	-	-	-	-	152.66	173.9

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.